4//SEC Filing
Ottinger Bradley 4
Accession 0000805928-23-000026
CIK 0000805928other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:50 PM ET
Size
14.7 KB
Accession
0000805928-23-000026
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Ottinger Bradley
General Counsel and CCO
Transactions
- Tax Payment
Common Stock
2023-03-16$8.27/sh−1,836$15,184→ 23,627 total - Exercise/Conversion
Common Stock
2023-03-16+2,563→ 25,463 total - Exercise/Conversion
Restricted Stock Units
2023-03-16−2,563→ 2,564 total→ Common Stock (2,563 underlying) - Exercise/Conversion
Common Stock
2023-03-16+5,900→ 23,698 total - Tax Payment
Common Stock
2023-03-16$8.27/sh−798$6,599→ 22,900 total - Exercise/Conversion
Restricted Stock Units
2023-03-16−5,900→ 5,900 total→ Common Stock (5,900 underlying)
Footnotes (6)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2023.
- [F2]Includes 3,000 shares acquired under the Axogen stock purchase plan in 2022.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (3 years from the grant date) based upon a vesting schedule whereby 33.33% of the aggregate shares vest on March 16, 2022, 33.33% of the aggregate shares vest on March 16, 2023, and 33.34% of the aggregate shares vest on March 16, 2024. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001813381
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:50 PM ET
- Size
- 14.7 KB